Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 137

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4A
Chunk 137
---
 Additionally, in the past Mr. Falk held
various executive positions in Orbotech Ltd. between 1985 and 1999, and Sapiens International Corporation (Nasdaq: SPNS) between 1999-2001.
Mr. Falk holds a B. A. in Economics and Political Sciences, and an M. A. in Business Administration both from the Hebrew University of Jerusalem,
Israel.

Dr. Adrian
Percyhas served as a director of our Company since February 2019. Dr. Percy serves on the board of directors of AgPlenus
Ltd., BioLumic Ltd., Nufarm Ltd. and FungiAlert Inc. (dba FA Bio). He is a member of the science and technology boards
of Harpe BioHerbicide Solutions Inc., and Biotalys NV. Dr. Percy is serving as the Executive Director of the N. C. Plant Sciences
Initiative and is a Professor in the Department of Plant and Microbial Biology at North Carolina State University since 2021. Dr.
Percy is currently a venture partner with DYDX Capital and frequently acts as an advisor to companies through his own consultancy
company, Nomad Technology Consulting. From 2019-2021, Dr. Percy served as Chief Technology Officer at UPL Ltd. From 2014-2018, he served
as the head of research and development for the Crop Science division of Bayer as part of its executive committee. During his 16-year
tenure at Bayer, he also led regulatory affairs activities across the entire division of Crop Science between 2013 and 2014 and crop protection
development activities for Bayer in North America between 2011 and 2013. Dr. Percy has held positions in the research and development
departments of Aventis CropScience SA between 2000 and 2002, Rhone Poulenc SA between 1996 and 2000, and Bayer in France, Germany and
the United States. Dr. Percy earned a bachelor’s degree in pharmacology at the University of Liverpool, England, as well as a master’s
degree in toxicology and a doctorate in biochemistry at the University of Birmingham, England.

Mr. Leon Y.
Recanatihas served as a director of our Company since May 2005. Mr. Recanati has served as chairperson and chief executive
officer of GlenRock Israel Ltd. since 2003. Previously, Mr. Recanati was chief executive